ICE Bioscience Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 471

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 13

ICE Bioscience General Information

Description

Provider of integrated drug discovery and preclinical research services intended for biopharmaceutical companies, biotechnology firms, and research institutions. The company offers target validation, lead compound discovery, and pharmacology services, enabling drug developers to accelerate the identification of clinical candidates and optimize the drug development process.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 15, Fengchuang Science and Technology Park
  • No. 18, Kechuang 13th Street
  • Beijing, 100176
  • China
+86 010
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • Building 15, Fengchuang Science and Technology Park
  • No. 18, Kechuang 13th Street
  • Beijing, 100176
  • China
+86 010

ICE Bioscience Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ICE Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. IPO 24-Jun-2026 Announced Profitable
12. Secondary Transaction - Private 24-Dec-2025 Completed Profitable
11. IPO 22-Jan-2025 Completed Profitable
10. Secondary Transaction - Private 25-Apr-2024 Completed Generating Revenue
9. Later Stage VC (Series B1) 25-Apr-2024 Completed Generating Revenue
8. Later Stage VC (Series B) 27-Sep-2023 Completed Generating Revenue
7. Later Stage VC (Series A2) 19-Jan-2023 Completed Generating Revenue
6. Later Stage VC (Series A1) 06-Sep-2022 Completed Generating Revenue
5. Secondary Transaction - Private 23-Nov-2021 $1.76M $6.08M Completed Generating Revenue
4. Grant 01-Aug-2021 $1.08M $6.08M Completed Generating Revenue
To view ICE Bioscience’s complete valuation and funding history, request access »

ICE Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 1,985,294 $2.35 $2.35 1x $2.35 10.34%
Ordinary 740,740 $0.93 $0.93 1x $0.93 3.86%
To view ICE Bioscience’s complete cap table history, request access »

ICE Bioscience Patents

ICE Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7942623-B2 A potent and selective inhibitor of the calcium-activated potassium channel kca3.1 for use as a platform therapeutic agent. Active 30-Nov-2020
JP-2024503571-A A potent and selective inhibitor of the calcium-activated potassium channel kca3.1 for use as a platform therapeutic. Active 30-Nov-2020
AU-2021387535-A1 Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics Pending 30-Nov-2020
AU-2021387535-A9 Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics Pending 30-Nov-2020
CA-3203637-A1 Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics Pending 30-Nov-2020 C07D211/90
To view ICE Bioscience’s complete patent history, request access »

ICE Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ICE Bioscience Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing E-town International Industrial Investment Management Government Minority
Alwin Capital Venture Capital Minority
Shanghai Yuanjin Herun Private Equity Fund Management Growth/Expansion Minority
Addor Capital Growth/Expansion Minority
CICC Capital PE/Buyout Minority
You’re viewing 5 of 13 investors. Get the full list »

ICE Bioscience FAQs

  • When was ICE Bioscience founded?

    ICE Bioscience was founded in 2010.

  • Where is ICE Bioscience headquartered?

    ICE Bioscience is headquartered in Beijing, China.

  • What is the size of ICE Bioscience?

    ICE Bioscience has 471 total employees.

  • What industry is ICE Bioscience in?

    ICE Bioscience’s primary industry is Laboratory Services (Healthcare).

  • Is ICE Bioscience a private or public company?

    ICE Bioscience is a Private company.

  • What is ICE Bioscience’s current revenue?

    The current revenue for ICE Bioscience is .

  • How much funding has ICE Bioscience raised over time?

    ICE Bioscience has raised $46.1M.

  • Who are ICE Bioscience’s investors?

    Beijing E-town International Industrial Investment Management, Alwin Capital, Shanghai Yuanjin Herun Private Equity Fund Management, Addor Capital, and CICC Capital are 5 of 13 investors who have invested in ICE Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process